Nucleus subthalamicus Stimulation bei Morbus Parkinson

B. Haslinger

doi:10.1055/s-0038-1626785

Nervenheilkunde, Table of Contents

Nervenheilkunde 2006; 25(10): 816-824
DOI: 10.1055/s-0038-1626785

Originaler Artikel

Schattauer GmbH

Nucleus subthalamicus Stimulation bei Morbus Parkinson

Indikation, klinische Effektivität und mögliche WirkmechanismenStimulation of the subthalamic nucleus in Parkinson’s disease

B. Haslinger

¹Neurologische Klinik der TU-München

› Author Affiliations

Abstract

Zusammenfassung

Die operative Behandlung des Morbus Parkinson (MP) mittels Hochfrequenz-Tiefenhirnstimulation (DBS) im Bereich des Nucleus subthalamicus (STN) hat sich im Verlauf der letzten Jahre beinahe als Routineverfahren zur Behandlung fortgeschrittener Erkrankungsstadien etabliert. Die DBS zielt dabei vor allem auf die Behandlung von Patienten mit schweren motorischen Komplikationen wie Wirkungsfluktuationen und Dyskinesien ab. Zur Erzielung eines guten operativen Ergebnisses ist die sorgfältige Selektion geeigneter Patienten eine unabdingbare Voraussetzung. Hierbei ist vor allem auf ein gutes Ansprechen der Symptome auf L-Dopa sowie auf eine geringe psychiatrische und internistische Komorbidität zu achten. Langzeitstudien zur STN DBS konnten mittlerweile signifikante und anhaltende Besserungen der motorischen Fähigkeiten im medikamentösen Off über 3 bis 5 Jahre nachweisen. Der Wirkungsmechanismus der DBS wird aber weiterhin schlecht verstanden. Diverse elektrophysiologische Daten sprechen gegen die nahe liegende Hypothese einer rein läsionellen Inaktivierung des überaktiven STN. Vielmehr sprechen neuere Daten eher für eine aktive Stimulation neuronaler Elemente durch die STN DBS. Unter Umständen könnte die DBS hierdurch in der Art eines Störsenders eine rhythmische prokinetische Aktivität in beim MP pathologisch oszillierende Netzwerke einspeisen.

Summary

High-frequency deep brain stimulation (DBS) within the subthalamic nucleus (STN) has become a widely-used surgical treatment for advanced stages of idiopathic Parkinson’s disease (PD). Severe motor complications like fluctuations and dyskinesias are the main indication for DBS in PD. Careful selection of patients suitable for DBS includesa good response to levodopa anda lack of major psychiatric and general medical comorbidity. Longterm studies of STN DBS have reporteda significant and sustained improvement of motor symptoms even 3 to 5 years post-operatively. Nevertheless, the main mechanism of action of DBS is still unclear. New data suggest that beyond simple ablation of the hyperactive STN, DBS rather allows an active modulation of neuronal circuits. Here, DBS could superimpose rhythmical activity onto pathologically oscillating neuronal networks in PD.

Schlüsselwörter

Morbus Parkinson - Tiefenhirnstimulation - Nucleus subthalamicus

Keywords

Parkinson’s disease - deep brain stimulation - subthalamic nucleus

Full Text

References

Literatur
1 Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989; 12: 366-75.
2 Alvarez L. et al. Bilateral subthalamotomy in Parkinson’s disease: initial and long-term response. Brain 2005; 128 (Pt 3): 570-83.
3 Ashby P. et al. Potentials recorded at the scalp by stimulation near the human subthalamic nucleus. Clin Neurophysiol 2001; 112: 431-7.
4 Bejjani BP. et al. Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry 2000; 68: 595-600.
5 Benabid AL. et al. Acute and long-term effects of subthalamic nucleus stimulation in Parkinson’s disease. Stereotact Funct Neurosurg 1994; 62: 76-84.
6 Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol 1987; 50: 344-6.
7 Benazzouz A, Gao DM, Ni ZG, Piallat B, Bouali-Benazzouz R, Benabid AL. Effect of high-frequency stimulation of the subthalamic nucleus on the neuronal activities of the substantia nigra pars reticulata and ventrolateral nucleus of the thalamus in the rat. Neuroscience 2000; 99: 289-95.
8 Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990; 249 (4975): 1436-8.
9 Beurrier C, Bioulac B, Audin J, Hammond C. High-frequency stimulation produces a transient blockade of voltage-gated currents in subthalamic neurons. J Neurophysiol 2001; 85: 1351-6.
10 Bevan MD, Wilson CJ. Mechanisms underlying spontaneous oscillation and rhythmic firing in rat subthalamic neurons. J Neurosci 1999; 19: 7617-28.
11 Ceballos-Baumann AO. et al. A positron emission tomographic study of subthalamic nucleus stimulation in Parkinson disease: enhanced movement-related activity of motor-association cortex and decreased motor cortex resting activity. Arch Neurol 1999; 59: 997-1003.
12 Charles PD. et al. Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology 2002; 59: 932-4.
13 Dauper J. et al. Effects of subthalamic nucleus (STN) stimulation on motor cortex excitability. Neurology 2002; 59: 700-6.
14 DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990; 13: 281-5.
15 Dostrovsky JO, Levy R, Wu JP, Hutchison WD, Tasker RR, Lozano AM. Microstimulation-induced inhibition of neuronal firing in human globus pallidus. J Neurophysiol 2000; 84: 570-4.
16 Funkiewiez A. et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2004; 75: 834-9.
17 Garcia L, D’Alessandro G, Bioulac B, Hammond C. High-frequency stimulation in Parkinson’s disease: more or less?. Trends Neurosci 2005; 28: 209-16.
18 Goldberg JA, Boraud T, Maraton S, Haber SN, Vaadia E, Bergman H. Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson’s disease. J Neurosci 2002; 22: 4639-53.
19 Hanajima R, Ashby P, Lozano AM, Lang AE, Chen R. Single pulse stimulation of the human subthalamic nucleus facilitates the motor cortex at short intervals. J Neurophysiol 2004; 92: 1937-43.
20 Hashimoto T, Elder CM, Okun MS, Patrick SK, Vitek JL. Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. J Neurosci 2003; 23: 1916-23.
21 Haslinger B. et al. Differential modulation of subcortical target and cortex during deep brain stimulation. Neuroimage 2003; 18: 517-24.
22 Haslinger B. et al. Event-related functional magnetic resonance imaging in Parkinson’s disease before and after levodopa. Brain 2001; 124 (Pt 3): 558-70.
23 Haslinger B, Kalteis K, Boecker H, Alesch F, Ceballos-Baumann AO. Frequency-correlated decreases of motor cortex activity associated with subthalamic stimulation in Parkinson’s disease. Neuroimage 2005; 28: 598-606.
24 Hershey T. et al. Cortical and subcortical blood flow effects of subthalamic nucleus stimulation in PD. Neurology 2003; 61: 816-821.
25 Hilker R. et al. Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans. Mov Disord 2003; 18: 41-8.
26 Hilker R, Voges J, Thiel A, Ghaemi M, Herholz K, Sturm V, Heiss WD. Deep brain stimulation of the subthalamic nucleus versus levodopa challenge in Parkinson’s disease: measuring the on- and offconditions with FDG-PET. J Neural Transm 2002; 109: 1257-64.
27 Holsheimer J, Demeulemeester H, Nuttin B, de Sutter P. Identification of the target neuronal elements in electrical deep brain stimulation. Eur J Neurosci 2000; 12: 4573-7.
28 Houeto JL. et al. Behavioural disorders, Parkinson’s disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002; 72: 701-7.
29 Krack P. et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 2003; 349: 1925-34.
30 Krack P. et al. Ineffective subthalamic nucleus stimulation in levodopa-resistant postischemic parkinsonism. Neurology 2000; 54: 2182-4.
31 Krack P. et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson’s disease. Brain 1998; 121 (Pt 3): 451-7.
32 Laitinen LV, Bergenheim AT, Hariz MI. Leksell’s posteroventral pallidotomy in the treatment of Parkinson’s disease. J Neurosurg 1992; 76: 53-61.
33 Limousin P, Greene J, Pollak P, Rothwell J, Benabid AL, Frackowiak R. Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson’s disease. Ann Neurol 1997; 42: 283-91.
34 Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL. Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 1998; 339: 1105-11.
35 Limousin P, Speelman JD, Gielen F, Janssens M. Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry 1999; 66: 289-96.
36 Lozano AM, Dostrovsky J, Chen R, Ashby P. Deep brain stimulation for Parkinson’s disease: disrupting the disruption. Lancet Neurol 2002; 01: 225-31.
37 Magill PJ, Bolam JP, Bevan MD. Relationship of activity in the subthalamic nucleus-globus pallidus network to cortical electroencephalogram. J Neurosci 2000; 20: 820-33.
38 McIntyre CC, Grill WM. Excitation of central nervous system neurons by nonuniform electric fields. Biophys J 1999; 76: 878-88.
39 Meissner W, Reum T, Paul G, Harnack D, Sohr R, Morgenstern R, Kupsch A. Striatal dopaminergic metabolism is increased by deep brain stimulation of the subthalamic nucleus in 6-hydroxydopamine lesioned rats. Neurosci Lett 2001; 303: 165-8.
40 Nambu A, Tokuno H, Takada M. Functional significance of the cortico-subthalamo-pallidal ‘hyperdirect’ pathway. Neurosci Res 2002; 43: 111-7.
41 Nowak LG, Bullier J. Axons, but not cell bodies, are activated by electrical stimulation in cortical gray matter. II. Evidence from selective inactivation of cell bodies and axon initial segments. Exp Brain Res 1998; 118: 489-500.
42 Orieux G, Francois C, Feger J, Hirsch EC. Consequences of dopaminergic denervation on the metabolic activity of the cortical neurons projecting to the subthalamic nucleus in the rat. J Neurosci 2002; 22: 8762-70.
43 Pinter MM, Alesch F, Murg M, Helscher RJ, Binder H. Apomorphine test: a predictor for motor responsiveness to deep brain stimulation of the subthalamic nucleus. J Neurol 1999; 246: 907-13.
44 Ridding MC, Inzelberg R, Rothwell JC. Changes in excitability of motor cortical circuitry in patients with Parkinson’s disease. Ann Neurol 1995; 37: 181-8.
45 Rodriguez-Oroz MC. et al. Bilateral deep brain stimulation in Parkinson’s disease: a multicentre study with 4 years follow-up. Brain. 2005
46 Saint-Cyr JA, Trepanier LL, Kumar R, Lozano AM, Lang AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson’s disease. Brain 2000; 123 (Pt 10): 2091-108.
47 Schroeder U. et al. Subthalamic nucleus stimulation affects striato-anterior cingulate cortex circuit in a response conflict task: a PET study. Brain 2002; 125 (Pt 9): 1995-2004.
48 Schroeder U. et al. Subthalamic nucleus stimulation affects a frontotemporal network: a PET study. Ann Neurol 2003; 54: 445-50.
49 Schuurman PR. et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 2000; 342: 461-8.
50 Siegfried J, Lippitz B. Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery 1994; 35: 1126-9 discussion 1129–30..
51 Stefani A. et al. Subthalamic stimulation activates internal pallidus: evidence from cGMP microdialysis in PD patients. Ann Neurol 2005; 57: 448-52.
52 Strafella AP, Sadikot AF, Dagher A. Subthalamic deep brain stimulation does not induce striatal dopamine release in Parkinson’s disease. Neuroreport 2003; 14: 1287-9.
53 The Deep-Brain Stimulation for Parkinson’s Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med 2001; 345: 956-63.
54 Walter BL, Vitek JL. Surgical treatment for Parkinson’s disease. Lancet Neurol 2004; 03: 719-28.
55 Welter ML. et al. Effects of high-frequency stimulation on subthalamic neuronal activity in parkinsonian patients. Arch Neurol 2004; 61: 89-96.
56 Welter ML. et al. Clinical predictive factors of subthalamic stimulation in Parkinson’s disease. Brain 2002; 125 (Pt 3): 575-83.
57 Windels F, Bruet N, Poupard A, Feuerstein C, Bertrand A, Savasta M. Influence of the frequency parameter on extracellular glutamate and gammaaminobutyric acid in substantia nigra and globus pallidus during electrical stimulation of subthalamic nucleus in rats. J Neurosci Res 2003; 72: 259-67.
58 Windels F, Bruet N, Poupard A, Urbain N, Chouvet G, Feuerstein C, Savasta M. Effects of high frequency stimulation of subthalamic nucleus on extracellular glutamate and GABA in substantia nigra and globus pallidus in the normal rat. Eur J Neurosci 2000; 12: 4141-6.